available for iOS, Android & web
April 04, 2012
The colorectal cancer drug market in China is set to grow from a value of $261 million in 2011 to $404 million in 2016, and a key factor driving this fast growth will be the increased used of targeted therapies, according to a new report.
Making patients smile
Patients’ wellbeing can be just as important as
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions